Drug intelligence / Profile preview

Cauterex

Development stage
Phase 2
Lead developer
Megat Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Cauterex is a topical analgesic cream developed and marketed by Megat Pharmaceutical in Ecuador. Its active ingredient is capsaicin (0.075%), derived from the dried extract of *Capsicum annuum* L. Capsaicin acts as a selective agonist for the transient receptor potential vanilloid 1 (TRPV1) receptor, which is primarily expressed on nociceptive nerve fibers. Initial application typically causes a localized burning sensation, but repeated use leads to the desensitization of sensory axons and the depletion of substance P, a neurotransmitter involved in pain signaling. Cauterex is indicated for the relief of various pain conditions, including neuropathic pain, muscle pain, and arthritis.

Brand names
Cauterex
Other names
capsaicin
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on Cauterex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cauterex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call